• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 10 - 14, 2014

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

February 10 - 14, 2014
FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 2/11/14 Delhi, India Mary Lou Valdez, Erica Jefferson, and Altaf Lal N/A CEO Roundtable of the Pharmaceutical Industry
Elizabeth H. Dickinson, Esq., Chief Counsel 2/10/14-2/14/14 Silver Spring, MD Janet Woodcock, Leslie Kux, Karen Schifter, Sally Howard Doug Lankler, Jeffrey Chasnow, Geoffrey Levitt, Ed Harrigan (Pfizer) Medical Comunications
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine 2/13/2014 Teleconference William Flynn, Tracey Forfa, Neal Bataller KJ Varma, John Rogers (Merck Animal Health) Drug approval process
Walter S. Harris, M.B.A, P.M.P., Deputy Commissioner for Operations and Chief Operating Officer 2/10/2014 Bethesda, MD N/A Stephanie C. Hill Lockheed Martin African American Leadership Forum Customer Panel
Sally Howard, J.D.
Deputy Commissioner for Policy, Planning, and Legislation and Acting Associate Commissioner for Legislation
2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Steven Immergut, Acting Associate Commissioner for External Affairs 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Peter Lurie, M.D., M.P.H., Acting Associate Commissioner for Policy and Planning 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Stephen M. Ostroff, M.D., Acting Chief Scientist 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Melinda K. Plaiser, Associate Commissioner for Regulatory Affairs 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Howard Sklamberg, J.D., Deputy Commissioner for Global Regulatory Operations and Policy 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine 2/12/14 Washington, DC Tracey Sanders, Linda Harris, Samir Assar, Kari Barrett Joel Nelsen, Kevin Severns (California Citrus Mutual), Robert Schramm (Schramm, Williams & Associates) Food Safety Modernization Act
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine 2/12/14 College Park, MD Tracey Sanders, Kathy Gombas, Dan McChesney, Sharon Mayl, Kari Barrett, Laura Pillsbury, Charlotte Christin, Samir Assar, (following by phone) Kim Young, Eric Nelson, Cathie Marshall, Martine Hartogensis, Brian Pendleton Cindy Kruger, Scott Brooks, Rene’ Lanners, Joel Leftwich (Pepsico) Food Safety Modernization Act
Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research 2/12/14-2/13/14 Silver Spring, MD Robert Temple, Jennifer Pippins, Patrick Frey Howard Heinz (Carnegie Mellon University), Robert Ratner (American Diabetes Association), Tarek Hammad (Merck and Company), Deborah Zarin (National Institutes of Health), Michaela Kiernan (Stanford School of Medicine), Sebastian Schneeweiss (Harvard Medical School) Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: An Institute of Medicine Workshop
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products 2/10/14 – 2/14/14 N/A N/A N/A No Significant Meetings